-
Press Release
New Novartis ESC data highlights strength of cardiovascular portfolio
-
Story
Negative impact of the IRA on patient access to innovative treatments -
Press Release
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
-
Press Release
Novartis completes tender offer for all outstanding shares of The Medicines Company
-
Press Release
Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran
-
Press Release
Novartis receives simultaneous approval for five new products from Japanese Ministry of Health, Labour and Welfare, offering Japanese patients a broad range of novel treatment options
-
Story
Surviving with heart failure -
Story
Most Europeans have limited awareness about heart failure -
Story
Living with HFpEF – a patient’s story -
Story
Living with heart failure -
Story
Heart failure: coping with one of the world’s biggest killers -
Story
Caring for someone with heart failure